Análise das Infecções Sexualmente Transmissíveis durante a pandemia da COVID-19 no Brasil
##plugins.themes.bootstrap3.article.sidebar##
Publicado
Aug 27, 2024
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Analisar a tendência e o impacto que COVID-19 teve nas notificações de IST (HIV/Aids, Sífilis, HBV e HCV) no Brasil. Métodos: Trata-se de um estudo ecológico, de tendência temporal das notificações de IST pela taxa de detecção das infecções no Brasil, de 2015 a 2021. A análise de tendência de 2015 a 2021 foi realizada por meio de um modelo de regressão linear para séries histórica. Para avaliar o impacto da pandemia, os casos esperados foram comparados com os casos observados para os anos de 2015 a 2021. Foi estabelecido um nível de significância de 5%, as análises de tendência foram conduzidas usando o Programa Joinpoint Regression e os valores estimados por meio do Programa R. Resultados: Os resultados demonstram que houve um decréscimo acentuado das taxas de detecção de IST de notificação compulsória no Brasil durante o período pandêmico da Covid-19 e isso se refletiu em todas as regiões do Brasileiras. Conclusão: Durante a pandemia de COVID-19 houve uma redução das notificações de IST. Esses resultados corroboram para estabelecimento de estratégias de vigilância e atenção à saúde para minimizar os impactos no atraso do diagnóstico e tratamento dessas infecções.
##plugins.themes.bootstrap3.article.details##
Como Citar
SousaR. F. V. de, MalletJ. R. dos S., NascimentoE. F. do, CardosoD. R. F., NevesJ. M. M., & OliveiraB. F. A. de. (2024). Análise das Infecções Sexualmente Transmissíveis durante a pandemia da COVID-19 no Brasil. Revista Eletrônica Acervo Saúde, 24(8), e18163. https://doi.org/10.25248/reas.e18163.2024
Seção
Artigos Originais
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1. BARBEE LA, et al. “Sex in the Time of COVID”: Clinical Guidelines for Sexually Transmitted Disease Management in an Era of Social Distancing. Sexually Transmitted Diseases, 2020; 47(7): 427–430.
2. BOTTURA BR, et al. Perfil epidemiológico da sífilis gestacional e congênita no Brasil – período de 2007 a 2016. Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo, 2019; 64(2): 69.
3. CAVALCANTE JR, et al. COVID-19 no Brasil: evolução da epidemia até a semana epidemiológica 20 de 2020. Epidemiologia e Serviços de Saúde, 2020; 29(4): 2020376.
4. CDC. Sexually Transmitted Disease Surveillance 2020. Centers for Disease Control and Prevention, 2023.
5. CRANE MA, et al. Reporting of sexually transmitted infections during the COVID-19 pandemic. Sexually Transmitted Infections, 2021; 97(2): 101–102.
6. DE BAETSELIER I, et al. The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium. Results of an sexually transmitted infection clinic. International Journal of STD and AIDS, 2021; 32(11): 998–1003.
7. DOMINGUES CSB, et al. Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: vigilância epidemiológica. Epidemiologia e Serviços de Saúde, 2021; 30(1).
8. EIBSCHUTZ LS, et al. Global Impact of COVID‐19 on Healthcare Systems. Coronavirus Disease 2019 (COVID‐19), 2023; 615–650.
9. FERNÀNDEZ-LÓPEZ L, et al. Impact of the COVID-19 pandemic on community-based testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. European Journal of Public Health, 2023; 33(3): 528–535.
10. GATECHOMPOL S, et al. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Research and Therapy, 2021; 18(1): 28.
11. GHAZNAVI C, et al. Recent changes in the reporting of STIs in Japan during the COVID-19 pandemic. Sexually Transmitted Infections, 2022; sextrans-2021-055378.
12. JOHNSON KA, et al. Measuring the Impact of the COVID-19 Pandemic on Sexually Transmitted Diseases Public Health Surveillance and Program Operations in the State of California. Sexually Transmitted Diseases, 2021; 48(8): 606–613.
13. KANDA N, et al. Indirect impact of the COVID-19 pandemic on the incidence of non–COVID-19 infectious diseases: a region-wide, patient-based database study in Japan. Public Health, 2023; 214: 20–24.
14. KIM H-J, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 2000; 19(3): 335–351.
15. LIU M, et al. A Neglected Narrative in the COVID-19 Pandemic: Epidemiological and Clinical Impacts of the COVID-19 Outbreak on Syphilis. Clinical, Cosmetic and Investigational Dermatology, 2023; 16: 2485–2496.
16. MAITHUFI R, et al. The Impact of the COVID-19 pandemic on STI services in the Eastern Cape Province of South Africa. COVID – epidemiology & health services impacts, 2021; A232-A24.
17. PAGAOA M, et al. Trends in Nationally Notifiable Sexually Transmitted Disease Case Reports During the US COVID-19 Pandemic, January to December 2020. Sexually Transmitted Diseases, 2021; 48(10): 798–804.
18. PEREIRA GFM, et al. HIV/AIDS, STIs and viral hepatitis in Brazil: Epidemiological trends. Revista Brasileira de Epidemiologia, 2019; 22: 1–2.
19. SARKAR S, et al. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses. Journal of Medical Virology, 2021; 93(4): 2385–2395.
20. SENTÍS A, et al. The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact? BMC Public Health, 2021; 21(1): 1637.
21. SHIFERAW W, et al. A systematic review and meta-analysis of sexually transmitted infections and blood-borne viruses in travellers. Journal of Travel Medicine, 2024; 31(4): 038.
22. SILVA DL, et al. Estratégias de prevenção a IST realizadas por enfermeiros na atenção primaria a saúde: uma revisão integrativa. Brazilian Journal of Health Review, 2021; 4(2): 4028–4044.
23. SILVA EF de O, et al. Fatores associados ao aumento de infecções sexualmente transmissíveis no público idoso. Revista Eletrônica Acervo Saúde, 2023; 23(3): 11813.
24. SIMÕES D, et al. Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Eurosurveillance, 2020; 25(47).
25. SINKA K. The global burden of sexually transmitted infections. Clinics in Dermatology, 2024; 42(2): 110–118.
26. SOE NN, et al. Clinical features-based machine learning models to separate sexually transmitted infections from other skin diagnoses. Journal of Infection, 2024; 88(4): 106128.
27. WAGENLEHNER FME, et al. Klinik, Diagnostik und Therapie sexuell übertragbarer Infektionen. Deutsches Arzteblatt International, 2016; 113(1–2): 11–22.
28. WHO. Global hepatitis report 2024: action for access in low-and middle-income countries. World Health Organization, 2024.
29. WHO. HIV statistics, globally and by WHO region, 2023. World Health Organization, 2023.
30. WHO. Timeline of WHO’s response to COVID-19. World Health Organization, 2020.
31. WIHLFAHRT K, et al. Sexually Transmitted Diseases-An Update and Overview of Current Research. Diagnostics, 2023; 13(9): 1656.
32. WU X, et al. The Impact of COVID-19 Lockdown on Cases of and Deaths From AIDS, Gonorrhea, Syphilis, Hepatitis B, and Hepatitis C: Interrupted Time Series Analysis. JMIR Public Health and Surveillance, 2023; 9: 40591.
33. ZHENG Y, et al. Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. The Lancet Infectious Diseases, 2022; 22(4): 541–551.
2. BOTTURA BR, et al. Perfil epidemiológico da sífilis gestacional e congênita no Brasil – período de 2007 a 2016. Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo, 2019; 64(2): 69.
3. CAVALCANTE JR, et al. COVID-19 no Brasil: evolução da epidemia até a semana epidemiológica 20 de 2020. Epidemiologia e Serviços de Saúde, 2020; 29(4): 2020376.
4. CDC. Sexually Transmitted Disease Surveillance 2020. Centers for Disease Control and Prevention, 2023.
5. CRANE MA, et al. Reporting of sexually transmitted infections during the COVID-19 pandemic. Sexually Transmitted Infections, 2021; 97(2): 101–102.
6. DE BAETSELIER I, et al. The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium. Results of an sexually transmitted infection clinic. International Journal of STD and AIDS, 2021; 32(11): 998–1003.
7. DOMINGUES CSB, et al. Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: vigilância epidemiológica. Epidemiologia e Serviços de Saúde, 2021; 30(1).
8. EIBSCHUTZ LS, et al. Global Impact of COVID‐19 on Healthcare Systems. Coronavirus Disease 2019 (COVID‐19), 2023; 615–650.
9. FERNÀNDEZ-LÓPEZ L, et al. Impact of the COVID-19 pandemic on community-based testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. European Journal of Public Health, 2023; 33(3): 528–535.
10. GATECHOMPOL S, et al. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Research and Therapy, 2021; 18(1): 28.
11. GHAZNAVI C, et al. Recent changes in the reporting of STIs in Japan during the COVID-19 pandemic. Sexually Transmitted Infections, 2022; sextrans-2021-055378.
12. JOHNSON KA, et al. Measuring the Impact of the COVID-19 Pandemic on Sexually Transmitted Diseases Public Health Surveillance and Program Operations in the State of California. Sexually Transmitted Diseases, 2021; 48(8): 606–613.
13. KANDA N, et al. Indirect impact of the COVID-19 pandemic on the incidence of non–COVID-19 infectious diseases: a region-wide, patient-based database study in Japan. Public Health, 2023; 214: 20–24.
14. KIM H-J, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 2000; 19(3): 335–351.
15. LIU M, et al. A Neglected Narrative in the COVID-19 Pandemic: Epidemiological and Clinical Impacts of the COVID-19 Outbreak on Syphilis. Clinical, Cosmetic and Investigational Dermatology, 2023; 16: 2485–2496.
16. MAITHUFI R, et al. The Impact of the COVID-19 pandemic on STI services in the Eastern Cape Province of South Africa. COVID – epidemiology & health services impacts, 2021; A232-A24.
17. PAGAOA M, et al. Trends in Nationally Notifiable Sexually Transmitted Disease Case Reports During the US COVID-19 Pandemic, January to December 2020. Sexually Transmitted Diseases, 2021; 48(10): 798–804.
18. PEREIRA GFM, et al. HIV/AIDS, STIs and viral hepatitis in Brazil: Epidemiological trends. Revista Brasileira de Epidemiologia, 2019; 22: 1–2.
19. SARKAR S, et al. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses. Journal of Medical Virology, 2021; 93(4): 2385–2395.
20. SENTÍS A, et al. The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact? BMC Public Health, 2021; 21(1): 1637.
21. SHIFERAW W, et al. A systematic review and meta-analysis of sexually transmitted infections and blood-borne viruses in travellers. Journal of Travel Medicine, 2024; 31(4): 038.
22. SILVA DL, et al. Estratégias de prevenção a IST realizadas por enfermeiros na atenção primaria a saúde: uma revisão integrativa. Brazilian Journal of Health Review, 2021; 4(2): 4028–4044.
23. SILVA EF de O, et al. Fatores associados ao aumento de infecções sexualmente transmissíveis no público idoso. Revista Eletrônica Acervo Saúde, 2023; 23(3): 11813.
24. SIMÕES D, et al. Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Eurosurveillance, 2020; 25(47).
25. SINKA K. The global burden of sexually transmitted infections. Clinics in Dermatology, 2024; 42(2): 110–118.
26. SOE NN, et al. Clinical features-based machine learning models to separate sexually transmitted infections from other skin diagnoses. Journal of Infection, 2024; 88(4): 106128.
27. WAGENLEHNER FME, et al. Klinik, Diagnostik und Therapie sexuell übertragbarer Infektionen. Deutsches Arzteblatt International, 2016; 113(1–2): 11–22.
28. WHO. Global hepatitis report 2024: action for access in low-and middle-income countries. World Health Organization, 2024.
29. WHO. HIV statistics, globally and by WHO region, 2023. World Health Organization, 2023.
30. WHO. Timeline of WHO’s response to COVID-19. World Health Organization, 2020.
31. WIHLFAHRT K, et al. Sexually Transmitted Diseases-An Update and Overview of Current Research. Diagnostics, 2023; 13(9): 1656.
32. WU X, et al. The Impact of COVID-19 Lockdown on Cases of and Deaths From AIDS, Gonorrhea, Syphilis, Hepatitis B, and Hepatitis C: Interrupted Time Series Analysis. JMIR Public Health and Surveillance, 2023; 9: 40591.
33. ZHENG Y, et al. Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. The Lancet Infectious Diseases, 2022; 22(4): 541–551.